Independent · English-language
Israel's cannabis industry, in English.
Independent English-language news, data and analysis on Israel's medical cannabis market — regulation, companies, research and patient access.
Latest coverage
All news →- Cannabis Magazine (Hebrew)Patients & Medical
A joint on the balcony, a smell next door: the dispute splitting cannabis patients, neighbors — and lawyers
A feature examines the legal gray zone facing Israeli medical-cannabis patients who smoke at home, where neighbors odor complaints increasingly reach the courts and pit patients, residents and lawyers against one another over the limits of the right to medicate.
- Cannabis Magazine (Hebrew)Patients & Medical
Back on the rise: Israel's medical-cannabis patient count hits a record 143,900
Health Ministry figures for May 2026 put the number of licensed medical-cannabis patients in Israel at an all-time high of 143,900, resuming growth after a period of stagnation.
- Calcalist (Hebrew)Business & Markets
Surge in medical-cannabis demand opens the door to foreign workers in Israel's cultivation fields
A Calcalist report ties surging medical-cannabis demand to Israel's new pilot permitting licensed farms to employ foreign agricultural workers for the first time, aimed at easing a chronic labor shortage in the sector.
- Cannabis Magazine (Hebrew)Regulation & Policy
Tension in the Bennett–Lapid camp as 'Yachad' faction chief declines to state a position on legalization
A senior figure in the Bennett–Lapid political camp declined to take a public stance on recreational-cannabis legalization, exposing internal friction over how centrist parties should handle the issue.
- StratCannRegulation & Policy
Israel reopens anti-dumping investigation into Canadian medical cannabis imports
Israel has reopened an anti-dumping investigation into medical cannabis imported from Canada, a step that could lead to new duties on Canadian producers supplying the Israeli market.
- ice (Hebrew)Business & Markets
InterCure (Canndoc) raises ₪22M — with room to reach ₪54M — on rising German demand
Israel's largest listed cannabis operator announced a private placement priced above its Tel Aviv close, citing growing European demand and the new U.S. rescheduling backdrop.
- Cannabis Magazine (Hebrew)Regulation & Policy
Transport Minister Regev orders reporting of medical-cannabis patients who drive company cars — without the Health Ministry's knowledge
Israel’s Transport Ministry quietly told fleet safety officers to flag drivers of company, heavy or public vehicles who use medical cannabis and refer them for medical review — a step the Health Ministry says was taken without consulting its medical-cannabis unit and that appears to cut against court rulings protecting patients’ licenses.
- Cannabis Magazine (Hebrew)Patients & Medical
'Go take your drugs': leaked recordings of IDF disabled veterans' chief disparaging PTSD patients' cannabis spark uproar
In recordings aired by Channel 13, IDF Disabled Veterans Organization chairman Idan Kleiman is heard dismissing combat-PTSD veterans' medical cannabis as 'drugs', prompting demands for his removal against the backdrop of a High Court petition over a tenfold gap in housing benefits between physically and psychologically wounded soldiers.
- PR NewswireBusiness & Markets
IM Cannabis enters letter of intent to sell its European operations, cutting debt by ~C$10.5M
IMCC will sell its European arm — including Germany's Adjupharm — to a CEO-controlled entity to reduce debt and refocus on its core Israeli business.
- Cannabis Business TimesBusiness & Markets
InterCure completes first tranche of Botanico (ISHI) deal, weighs U.S. opportunities after rescheduling
Israel's largest listed operator adds American cannabis genetics and brands via Botanico and opens a strategic review of regulated U.S. markets.
- Cannabis Magazine (Hebrew)Business & Markets
Teva's distribution arm to handle Bazelet's products in a deal meant to rescue Israel's largest cannabis plant
Under a proposed creditor settlement, S.L.A — the pharmaceutical-distribution subsidiary of drug giant Teva — would pay ₪37.5 million into the debt fund in exchange for distributing Bazelet's products, against roughly ₪280 million in claims on the insolvent packaging and extraction maker.
- Cannabis Magazine (Hebrew)Regulation & Policy
Israeli police destroy 21,000 illegally grown cannabis plants in Negev operation
Police said a large-scale operation across the Negev uprooted roughly 21,000 illegally grown cannabis plants as part of an ongoing crackdown on illicit cultivation.